Publications
Cannabinoids for agitation in Alzheimer’s disease.
Outen JD, Burhanullah H, Vandrey R, Halima A, Harper DG, Patrick RE, Forester BP…Rosenberg, PB.
American Journal of Geriatric Psychiatry. 2021 Jan. DOI: 10.1016/j.jagp.2021.01.015.
Evolving Evidence for the Efficacy and Safety of ECT for Agitation in Alzheimer Disease.
Forester BP, Rahman AT, Harper DG, Petrides G.
The American Journal of Geriatric Psychiatry. 2020 Feb;28(2):164-166. doi: 10.1016/j.jagp.2019.10.013.
Lamotrigine Therapy and Biomarkers of Cerebral Energy Metabolism in Older Age Bipolar Depression.
Mellen EJ, Harper DG, Ravichandran C, Jensen E, Silveri M, Forester BP.
The American Journal of Geriatric Psychiatry. 2019 Aug;27(8):783-793. doi: 10.1016/j.jagp.2019.02.017.
Brain levels of high-energy phosphate metabolites and executive function in geriatric depression.
Harper DG, Joe EB, Jensen JE, Ravichandran C, Forester BP.
International Journal of Geriatric Psychiatry. 2016 Nov;31(11):1241-1249. doi: 10.1002/gps.4439.
Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression.
Harper DG, Jensen JE, Ravichandran C, Perlis RH, Fava M, Renshaw PF, Iosifescu DV.
Neuropsychopharmacology. 2017 Mar;42(4):876-885. doi: 10.1038/npp.2016.180.
Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression.
Forester BP, Harper DG, Georgakas J, Ravichandran C, Madurai N, Cohen BM.
Journal of Clinical Psychopharmacology. 2015 Jun;35(3):338-40. doi: 10.1097/JCP.0000000000000326.
Gray matter-specific changes in brain bioenergetics after acute sleep deprivation: a 31P magnetic resonance spectroscopy study at 4 Tesla.
Plante DT, Trksak GH, Jensen JE, Penetar DM, Ravichandran C, Riedner BA, Tartarini WL, Dorsey CM, Renshaw PF, Lukas SE, Harper DG.
Sleep. 2014 Dec 1;37(12):1919-27. doi: 10.5665/sleep.4242.
Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia.
Acharya D, Harper DG, Achtyes ED, Seiner SJ, Mahdasian JA, Nykamp LJ, Adkison L, Van der Schuur White L, McClintock SM, Ujkaj M, Davidoff DA, Forester BP.
International Journal of Geriatric Psychiatry. 2015 Mar;30(3):265-73. doi: 10.1002/gps.4137.
Noninvasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia.
Hu K, Harper DG, Shea SA, Stopa EG, Scheer FA.
Scientific Report. 2013;3:2229. doi: 10.1038/srep02229.
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
Woodward MR, Harper DG, Stolyar A, Forester BP, Ellison JM.
The American Journal of Geriatric Psychiatry. 2014 Apr;22(4):415-9. doi: 10.1016/j.jagp.2012.11.022.
Tissue-specific differences in brain phosphodiesters in late-life major depression.
Harper DG, Jensen JE, Ravichandran C, Sivrioglu Y, Silveri M, Iosifescu DV, Renshaw PF, Forester BP.
The American Journal of Geriatric Psychiatry. 2014 May;22(5):499-509. doi: 10.1016/j.jagp.2012.08.005.
Energetic and cell membrane metabolic products in patients with primary insomnia: a 31-phosphorus magnetic resonance spectroscopy study at 4 tesla.
Harper DG, Plante DT, Jensen JE, Ravichandran C, Buxton OM, Benson KL, O'Connor SP, Renshaw PF, Winkelman JW.
Sleep. 2013 Apr 1;36(4):493-500. doi: 10.5665/sleep.2530.
Depression in later life: an overview with treatment recommendations.
Ellison JM, Kyomen HH, Harper DG.
Psychiatric Clinics of North America. 2012 Mar;35(1):203-29. doi: 10.1016/j.psc.2012.01.003. Review.
Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia.
Ujkaj M, Davidoff DA, Seiner SJ, Ellison JM, Harper DG, Forester BP.
The American Journal of Geriatric Psychiatry. 2012 Jan;20(1):61-72. doi: 10.1097/JGP.0b013e3182051bbc.
Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.
Berlow YA, Wells WM, Ellison JM, Sung YH, Renshaw PF, Harper DG.
International Journal of Geriatric Psychiatry. 2010 Aug;25(8):780-8. doi: 10.1002/gps.2418.
Age-related changes in brain energetics and phospholipid metabolism.
Forester BP, Berlow YA, Harper DG, Jensen JE, Lange N, Froimowitz MP, Ravichandran C, Iosifescu DV, Lukas SE, Renshaw PF, Cohen BM.
NMR Biomedicine. 2010 Apr;23(3):242-50. doi: 10.1002/nbm.1444.
31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression.
Forester BP, Harper DG, Jensen JE, Ravichandran C, Jordan B, Renshaw PF, Cohen BM.
International Journal of Geriatric Psychiatry. 2009 Aug;24(8):788-97. doi: 10.1002/gps.2230.
Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia.
Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L, Kowall N, Satlin A.
Brain. 2008 Jun;131(Pt 6):1609-17. doi: 10.1093/brain/awn049. Epub 2008 Mar 27.
Disturbance of endogenous circadian rhythm in aging and Alzheimer disease.
Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A.
The American Journal of Geriatric Psychiatry. 2005 May;13(5):359-68.
Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.
Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, Volicer L.
Neurobiology of Aging. 2004 Jul;25(6):771-81.
Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration.
Harper DG, Stopa EG, McKee AC, Satlin A, Harlan PC, Goldstein R, Volicer L.
Archives of General Psychiatry. 2001 Apr;58(4):353-60.
For a more comprehensive list of Dr. Harper's publications, please click here.
Outen JD, Burhanullah H, Vandrey R, Halima A, Harper DG, Patrick RE, Forester BP…Rosenberg, PB.
American Journal of Geriatric Psychiatry. 2021 Jan. DOI: 10.1016/j.jagp.2021.01.015.
Evolving Evidence for the Efficacy and Safety of ECT for Agitation in Alzheimer Disease.
Forester BP, Rahman AT, Harper DG, Petrides G.
The American Journal of Geriatric Psychiatry. 2020 Feb;28(2):164-166. doi: 10.1016/j.jagp.2019.10.013.
Lamotrigine Therapy and Biomarkers of Cerebral Energy Metabolism in Older Age Bipolar Depression.
Mellen EJ, Harper DG, Ravichandran C, Jensen E, Silveri M, Forester BP.
The American Journal of Geriatric Psychiatry. 2019 Aug;27(8):783-793. doi: 10.1016/j.jagp.2019.02.017.
Brain levels of high-energy phosphate metabolites and executive function in geriatric depression.
Harper DG, Joe EB, Jensen JE, Ravichandran C, Forester BP.
International Journal of Geriatric Psychiatry. 2016 Nov;31(11):1241-1249. doi: 10.1002/gps.4439.
Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression.
Harper DG, Jensen JE, Ravichandran C, Perlis RH, Fava M, Renshaw PF, Iosifescu DV.
Neuropsychopharmacology. 2017 Mar;42(4):876-885. doi: 10.1038/npp.2016.180.
Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression.
Forester BP, Harper DG, Georgakas J, Ravichandran C, Madurai N, Cohen BM.
Journal of Clinical Psychopharmacology. 2015 Jun;35(3):338-40. doi: 10.1097/JCP.0000000000000326.
Gray matter-specific changes in brain bioenergetics after acute sleep deprivation: a 31P magnetic resonance spectroscopy study at 4 Tesla.
Plante DT, Trksak GH, Jensen JE, Penetar DM, Ravichandran C, Riedner BA, Tartarini WL, Dorsey CM, Renshaw PF, Lukas SE, Harper DG.
Sleep. 2014 Dec 1;37(12):1919-27. doi: 10.5665/sleep.4242.
Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia.
Acharya D, Harper DG, Achtyes ED, Seiner SJ, Mahdasian JA, Nykamp LJ, Adkison L, Van der Schuur White L, McClintock SM, Ujkaj M, Davidoff DA, Forester BP.
International Journal of Geriatric Psychiatry. 2015 Mar;30(3):265-73. doi: 10.1002/gps.4137.
Noninvasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia.
Hu K, Harper DG, Shea SA, Stopa EG, Scheer FA.
Scientific Report. 2013;3:2229. doi: 10.1038/srep02229.
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
Woodward MR, Harper DG, Stolyar A, Forester BP, Ellison JM.
The American Journal of Geriatric Psychiatry. 2014 Apr;22(4):415-9. doi: 10.1016/j.jagp.2012.11.022.
Tissue-specific differences in brain phosphodiesters in late-life major depression.
Harper DG, Jensen JE, Ravichandran C, Sivrioglu Y, Silveri M, Iosifescu DV, Renshaw PF, Forester BP.
The American Journal of Geriatric Psychiatry. 2014 May;22(5):499-509. doi: 10.1016/j.jagp.2012.08.005.
Energetic and cell membrane metabolic products in patients with primary insomnia: a 31-phosphorus magnetic resonance spectroscopy study at 4 tesla.
Harper DG, Plante DT, Jensen JE, Ravichandran C, Buxton OM, Benson KL, O'Connor SP, Renshaw PF, Winkelman JW.
Sleep. 2013 Apr 1;36(4):493-500. doi: 10.5665/sleep.2530.
Depression in later life: an overview with treatment recommendations.
Ellison JM, Kyomen HH, Harper DG.
Psychiatric Clinics of North America. 2012 Mar;35(1):203-29. doi: 10.1016/j.psc.2012.01.003. Review.
Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia.
Ujkaj M, Davidoff DA, Seiner SJ, Ellison JM, Harper DG, Forester BP.
The American Journal of Geriatric Psychiatry. 2012 Jan;20(1):61-72. doi: 10.1097/JGP.0b013e3182051bbc.
Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.
Berlow YA, Wells WM, Ellison JM, Sung YH, Renshaw PF, Harper DG.
International Journal of Geriatric Psychiatry. 2010 Aug;25(8):780-8. doi: 10.1002/gps.2418.
Age-related changes in brain energetics and phospholipid metabolism.
Forester BP, Berlow YA, Harper DG, Jensen JE, Lange N, Froimowitz MP, Ravichandran C, Iosifescu DV, Lukas SE, Renshaw PF, Cohen BM.
NMR Biomedicine. 2010 Apr;23(3):242-50. doi: 10.1002/nbm.1444.
31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression.
Forester BP, Harper DG, Jensen JE, Ravichandran C, Jordan B, Renshaw PF, Cohen BM.
International Journal of Geriatric Psychiatry. 2009 Aug;24(8):788-97. doi: 10.1002/gps.2230.
Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia.
Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L, Kowall N, Satlin A.
Brain. 2008 Jun;131(Pt 6):1609-17. doi: 10.1093/brain/awn049. Epub 2008 Mar 27.
Disturbance of endogenous circadian rhythm in aging and Alzheimer disease.
Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A.
The American Journal of Geriatric Psychiatry. 2005 May;13(5):359-68.
Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.
Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, Volicer L.
Neurobiology of Aging. 2004 Jul;25(6):771-81.
Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration.
Harper DG, Stopa EG, McKee AC, Satlin A, Harlan PC, Goldstein R, Volicer L.
Archives of General Psychiatry. 2001 Apr;58(4):353-60.
For a more comprehensive list of Dr. Harper's publications, please click here.
CLICK HERE TO VOLUNTEER FOR RESEARCH
McLean Hospital • South Belknap • 115 Mill Street, Belmont, MA 02478 • (617) 855-2499